Medical Condition News

RSS

FDA approves ProStrakan's Rectiv for pain associated with anal fissures

ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv™ (nitroglycerin) Ointment 0.4 % for the treatment of moderate to severe pain associated with chronic anal fissures.

22 Jun 2011

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed enrollment in its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).

22 Jun 2011

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.

22 Jun 2011

Only 10% of patients with heart attack transferred to another hospital for PCI in recommended time

Only about 10 percent of patients with a certain type of heart attack who need to be transferred to another hospital for a PCI are transferred within the recommended time of 30 minutes, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

Scientists uncover novel mechanism linked to Spinocerebellar ataxia 7

A team of scientists, led by researchers at the University of California, San Diego School of Medicine, have uncovered a novel mechanism regulating gene expression and transcription linked to Spinocerebellar ataxia 7, an inherited neurological disorder.

22 Jun 2011

Multiple abstracts on QNEXA long-term clinical study to be presented at ADA 2011

VIVUS, Inc. today announced that multiple abstracts have been accepted for presentation at the upcoming American Diabetes Association (ADA) meeting to be held June 24th to June 28th, 2011, at the San Diego Convention Center, San Diego, CA.

22 Jun 2011

Innovative Nail after Lengthening method can extend short thighbone by 26 centimeters

The MedUni Vienna's University Department of Trauma Surgery at Vienna General Hospital is a leader in the field of treatment of traumatic bone defects caused by accidents. A severely shortened thighbone as the result of an accident has now been able to be extended by using the innovative NAL method, creating an increase of 26 centimetres in only eight months.

22 Jun 2011

Researchers identify natural mechanism linked with Huntington's disease

Johns Hopkins researchers have identified a natural mechanism that might one day be used to block the expression of the mutated gene known to cause Huntington's disease.

22 Jun 2011

UC Riverside research could lead to novel therapeutics for epileptic seizures

Researchers at the University of California, Riverside have made a discovery in the lab that could help drug manufacturers develop new antiepileptic drugs and explore novel strategies for treating seizures associated with epilepsy - a disease affecting about two million Americans.

22 Jun 2011

22nd Century submits IND to FDA for VLN cigarettes

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction, announced today that 22nd Century Limited, LLC submitted an Investigational New Drug Application (IND) to the U.S. Food & Drug Administration (FDA) for X-22, a prescription smoking cessation aid in development.

22 Jun 2011

Twelve institutions receive NPCRC and American Cancer Society grants for palliative care research

The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $2 million in research grants to researchers at 12 institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers.

22 Jun 2011

Researchers identify potential cause of hereditary, progressive blindness

Medics at the RUB have found the cause of hereditary, progressive blindness: they have identified the previously unknown protein CCDC66, the loss of which initially leads to night blindness and in due course usually results in complete blindness.

22 Jun 2011

AHA CEO praises FDA's new cigarette warning labels

The following is a statement by American Heart Association CEO Nancy Brown: New cigarette warning labels unveiled today by the Food and Drug Administration will help give us the momentum needed to eradicate tobacco use in our nation.

22 Jun 2011

Strathclyde scientists receive British Heart Foundation grant to study hypertension

Scientists at the University of Strathclyde's Institute of Pharmacy and Biomedical Sciences, have recently been awarded almost -155,000 by the British Heart Foundation to conduct a two year investigation aimed at improving the treatment of hypertension.

22 Jun 2011

Supreme Court accepts case that could shape field of personalized medicine

The U.S. Supreme Court, accepting a case that will shape the burgeoning business of personalized medicine, agreed to consider what types of diagnostic medical tests can be patented. The justices agreed today to hear an appeal from the Mayo Clinic, which is challenging a lower court decision backing two patents for determining the dosage of medicines to treat stomach diseases.

22 Jun 2011

Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD

Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.

22 Jun 2011

Positive topline results from Lipid Therapeutics LT-02 Phase IIb trial on ulcerative colitis

Lipid Therapeutics, a biotechnology company focused on novel treatments for inflammatory bowel disease, today announced positive topline results from a Phase IIb clinical trial with its lead product, LT-02, in patients with ulcerative colitis.

22 Jun 2011

Endocrine Practice journal publishes new clinical guidelines on hyperthyroidism

New clinical guidelines for optimal care of patients with hyperthyroidism, a condition when the thyroid gland produces more thyroid hormone than the body needs, which affects about one percent of Americans, appear in the current issue of Endocrine Practice, the journal of the American Association of Clinical Endocrinologists.

22 Jun 2011

Nine young clinical investigators earn recognition from Damon Runyon Cancer Research Foundation

The Damon Runyon Cancer Research Foundation named five new Damon Runyon Clinical Investigators at its spring 2011 Clinical Investigator Award Committee review.

22 Jun 2011

Pycnogenol, CoQ10 combination boost heart function

A recent study published in Panminerva Medica reveals that a Pycnogenol and Coenzyme Q10 combination taken by stable heart failure patients as an adjunct to medical treatment naturally strengthens the heart, increasing the blood volume ejected with each beat.

22 Jun 2011

Medical Condition News

FDA approves ProStrakan's Rectiv for pain associated with anal fissures

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Only 10% of patients with heart attack transferred to another hospital for PCI in recommended time

Scientists uncover novel mechanism linked to Spinocerebellar ataxia 7

Multiple abstracts on QNEXA long-term clinical study to be presented at ADA 2011

Innovative Nail after Lengthening method can extend short thighbone by 26 centimeters

Researchers identify natural mechanism linked with Huntington's disease

UC Riverside research could lead to novel therapeutics for epileptic seizures

22nd Century submits IND to FDA for VLN cigarettes

Twelve institutions receive NPCRC and American Cancer Society grants for palliative care research

Researchers identify potential cause of hereditary, progressive blindness

AHA CEO praises FDA's new cigarette warning labels

Strathclyde scientists receive British Heart Foundation grant to study hypertension

Supreme Court accepts case that could shape field of personalized medicine

Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD

Positive topline results from Lipid Therapeutics LT-02 Phase IIb trial on ulcerative colitis

Endocrine Practice journal publishes new clinical guidelines on hyperthyroidism

Nine young clinical investigators earn recognition from Damon Runyon Cancer Research Foundation

Pycnogenol, CoQ10 combination boost heart function

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News